
About AR TRADEX
AR TRADEX is a company founded in 2007. AR TRADEX offers products and services including API's and Pharma Machines.
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Legal Name Ar Tradex Private Limited
- Date of Incorporation 22 Mar, 2007
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹1.94 Cr
FY 2025 · +7% YoY
- Net Profit₹12.9 Lakh
FY 2025 · 7% margin
- EBITDA₹21.4 Lakh
FY 2025 · 11% margin
Associated legal entities of AR TRADEX
AR TRADEX operates through Ar Tradex Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ar Tradex Private Limited CIN U51103DL2007PTC160983 | Active | 22 Mar 2007 | New Delhi, Delhi | ₹1.9 Cr | – | 2 | View details |
Products & Services of AR TRADEX
AR TRADEX offers a comprehensive portfolio of products and services, including API's and Pharma Machines.
API's are manufactured and exported to support pharmaceutical applications
Pharma machines are provided for manufacturing processes in the pharmaceutical sector
Board of directors of Ar Tradex Private Limited (AR TRADEX)
Ar Tradex Private Limited is the primary company behind AR TRADEX. The board of Ar Tradex Private Limited currently have 2 directors; the longest-serving is Kiran Saxena, appointed in 2010. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kiran Saxena DIN 02019681 | Director | 01 Jul 2010 | 16 yrs 3 mo | Ar Tradex Private Limited |
| Narender Kumar Sharma DIN 08999284 | Director | 12 Dec 2020 | 5 yrs 9 mo | Ar Tradex Private Limited |
Financials of AR TRADEX
Figures of Ar Tradex Private Limited, the primary company behind AR TRADEX, for FY 2025. Revenue was ₹1.94 Cr (+7% year on year). Net profit was ₹12.9 Lakh (7% margin). EBITDA was ₹21.4 Lakh (11% margin). Revenue has grown at a compounded annual rate of +26% over three years and +10% over five years.
- ₹1.94 CrRevenue · FY 2025 · +7% YoY
- ₹12.9 LakhNet profit · 7% margin
- ₹21.4 LakhEBITDA · 11% margin
- ₹1 LakhPaid-up capital
- +26%Revenue CAGR, 3 years
- +10%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Ar Tradex Private Limited are on its company page.
Detailed financial statements for AR TRADEX
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to AR TRADEX
10 companies that operate in the same segment as AR TRADEX (Medical Equipment & Supplies), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Software and integrated solutions for surgical and radiotherapy applications | 1989 | Munchen, Bayern, Germany | USD 12.68 M | USD 1.18 M | 18 | |
Robotic waterjet system for prostate tissue removal is developed. | 2009 | Redwood City, California, United States | USD 348.84 M | USD 308.05 M | 756 | |
Collaborative surgical robotic systems are provided for hospital procedures. | 2014 | Cambridge, Cambridgeshire, United Kingdom | USD 1.32 B | – | – | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.17 M | – | 242 | |
Augmented reality systems for guiding surgical procedures are developed. | 2014 | Yokneam Illit, North District, Israel | USD 142.6 M | – | – | |
Manufacturer of imaging and surgical products | 1919 | Tokyo, Tokyo, Japan | – | USD 6.49 B | 35,933 | |
Injectable packaging, containment, and delivery solutions are manufactured. | 1923 | Exton, Pennsylvania, United States | – | USD 3.07 B | 10,600 | |
Rapid infusion systems are provided for critically ill patients. | 2012 | Durham, North Carolina, United States | USD 77.98 M | – | – | |
Mobile robots are manufactured for industries including healthcare and agriculture. | 2013 | Odense, Denmark | USD 81.44 M | – | 303 | |
Visualization systems for surgical procedures are developed using machine learning. | 2016 | Seattle, Washington, United States | USD 74.25 M | – | 52 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about AR TRADEX
AR TRADEX was founded in 2007.
The primary company behind AR TRADEX, Ar Tradex Private Limited, reported revenue of βΉ1.94 Cr for FY 2025, up 7% year on year.
AR TRADEX is recognized as an ISO 9001:2015 certified entity that operates across multiple sectors, including pharmaceuticals, chemicals, and biotechnology, where integrated solutions are provided for manufacturing optimization and risk minimization. Various products such as APIs, hospital equipments, and pharma machines are manufactured, imported, and exported to enhance customer productivity and asset efficiency. Core values like integrity and excellence are emphasized, with a global presence established in regions like North America and Vietnam to support industrial applications and quality improvements. Reliable services are delivered to assist in market control and industry-specific knowledge.
AR TRADEX offers API's and Pharma Machines.
AR TRADEX operates through Ar Tradex Private Limited.
The legal entities of AR TRADEX currently have 2 directors, including Kiran Saxena, Narender Kumar Sharma.